Decreased Right Hippocampal Volumes and Neuroprogression Markers in Adolescents with Bipolar Disorder

Inal-Emiroglu F. N., Resmi H., KARABAY N., Guleryuz H., BAYKARA H. B., Cevher N., ...More

NEUROPSYCHOBIOLOGY, vol.71, no.3, pp.140-148, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 71 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1159/000375311
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.140-148
  • Keywords: Hippocampal volumes, Adolescents, Bipolar disorder, Brain-derived neurotrophic factor, Nerve growth factor, GRAY-MATTER VOLUME, NEUROTROPHIC FACTOR, MOOD DISORDERS, SPECTRUM DISORDERS, LITHIUM TREATMENT, RATING-SCALE, HUMAN BRAIN, DEPRESSION, EXPRESSION, INCREASES
  • Dokuz Eylül University Affiliated: Yes


Objectives: The aim of the present study was to assess differences and correlations between the hippocampal volumes (HCVs), serum nerve growth factor (NGF), and brain-derived neurotrophic factor (BDNF) levels in adolescents with bipolar disorder (BP) compared to healthy controls. Methods: Using structural magnetic resonance imaging, we compared HCVs of 30 patients with euthymic BP who were already enrolled in a naturalistic clinical follow-up. For comparison, we enrolled 23 healthy controls between the ages of 13 and 19. The boundaries of the hippocampus were outlined manually. The BDNF and NGF serum levels were measured with the sandwich ELISA. Results: The groups did not differ in the right or left HCVs or in the NGF or BDNF serum levels. However, negative correlations were found between the right HCVs and the duration of the disorder and medication and positive correlations were found between the duration of the medications and the NGF and BDNF levels in the patient group. Additionally, positive correlations were found between the follow-up period and left normalized HCVs in both the BP and lithium-treated groups. Conclusions: The right HCVs may vary with illness duration and the medication used to treat BP; NGF and BDNF levels may be affected by long-term usage. Further research is needed to determine whether these variables and their structural correlates are associated with clinical or functional differences between adolescents with BP and healthy controls. (C) 2015 S. Karger AG, Basel